Official UK procurement notice
Purchase of Geister Peripheral and Major Vascular Access Instruments
Procurement agent: Cardiff and Vale University Health Board·On behalf of: Velindre University NHS Trust Please note NHS Wales Shared Services Partnership (hosted by Velindre University NHS Trust) will manage this procurement on behalf of the contracting authority. Due to having the same identifiers, we're unable to reflect this in the notice options.
What is being bought
Published requirement descriptionCardiff and Vale University Health Board, intends to award a contract to Medivate for the one off purchase of Geister Peripheral and Major Vascular Access Instruments. The University Hospital of Wales (UHW) operates as a Major Trauma Centre and provides regional vascular and trauma services, receiving referrals from across South and West Wales. Theatre capacity is being expanded, including the development of additional major trauma and hybrid theatres to support high‑complexity trauma and vascular surgery.Peripheral and major vascular instrument sets are required for use across multiple theatre settings, including elective vascular theatres, CEPOD emergency theatres, Major Trauma Centre theatres, and hybrid/endovascular suites. These instrument sets support the delivery of abdominal aortic repairs, carotid endarterectomies, lower limb revascularisation procedures, trauma‑related vascular repairs, and conversions from endovascular to open surgery.The existing instrument inventory currently comprises three major vascular sets and four peripheral sets, which are fully utilised for elective, endovascular, and reserved damage‑control activity. This utilisation limits availability for urgent and out‑of‑hours procedures. The procurement of additional instrument trays is required to maintain operational capacity, ensure cover for emergency, weekend, and trauma activity, and support continuity of elective services across planned and unplanned care pathways.
The lotProcurement structure
single lot · no lot value publishedLot #1Awarded
Procedure terms & legal framework
From the official record- Procedure method
- Direct award
- Legal basis
- UKPGA · 2023/54 Procurement Act 2023
- Notice status
- Awarded without competition
- Procurement threshold
- Unspecified in notice
- Regulatory regime
- Standard
- Commercial structure
- Stand-alone contract (no framework)
- Competition type
- Direct award (no call for competition)
- GPA / WTO covered
- Unspecified in notice
- Recurring procurement
- Unspecified in notice
- First published
- 16 Apr 2026, 14:50 BST
- Last source update
- 11 May 2026, 11:50 BST
- Authority reference
CAV-DCO-(26-27) 4- FTS notice number
2026/S 000-042909- Latest notice
- Contract details notice (UK7)
- Delivery area
- Official registry OCID
ocds-h6vhtk-06845bFind a Tender
- Why no open competition
- Single Suppliers Intellectual Property Exclusive Rights; Single Suppliers Technical Reasons
- Published justification
To maintain standardisation of both major and peripheral vascular access instrument sets across theatre environments, the use of Geister instruments is required. These instruments are necessary to ensure consistency of configuration and compatibility with the existing instrument inventory in use within the Health Board. Medivate is the sole authorised distributor of Geister vascular instruments within the UK, and no alternative suppliers are available to provide equivalent items.
- Risks
Instrument capacity and service resilience risk
Current instrument capacity is sufficient to support routine elective and endovascular activity but provides limited resilience for emergency, CEPOD, and Major Trauma Centre activity, particularly out of hours or following weekend use. A lack of available trays at peak times presents a risk to timely service delivery.
Clinical and equipment reliability risk
Existing capacity constraints increase reliance on frequent instrument cycling, creating pressure on available sets and contributing to an identified clinical risk associated with limited equipment availability and resilience. This has been assessed as a service-critical risk within existing risk management processes.
Decontamination and turnaround risk
While decontamination capacity is approved and available, the limited number of trays places pressure on turnaround times within the Hospital Sterile Services Department. This may result in workflow bottlenecks and reduced flexibility during periods of increased demand.
Training and operational transition risk
The introduction of additional trays requires familiarisation and training for operating theatre and decontamination staff. Although training will be delivered internally, there is a short-term risk of operational inefficiency during the transition period.
Asset disposal and compliance risk
The replacement of existing instruments requires compliant disposal in line with Clinical Engineering and asset management processes, although no data security risks are associated with the equipment.
Mitigation
The procurement of additional major and peripheral vascular access trays will increase instrument resilience, support 24/7 service availability, reduce reliance on rapid cycling, and improve decontamination workflow. Standardised tray configuration, internal training delivery, and managed disposal arrangements will mitigate operational, clinical, and compliance risks.
How it was run
Official notice- Submission deadline
- —
Timeline
27 Apr 2026 → 11 May 2026 · 2 dates- Standstill ends183 days ago27 Apr 2026, 23:59 BST
- Notice published170 days ago11 May 2026, 11:50 BST
Notice history
4 events · 3 releases on Find a Tender · since 16 Apr 2026- Transparency notice published16 Apr 2026, 14:50 BSTUK5
- Contract award notice published16 Apr 2026, 16:19 BSTUK6
- Contract signature expected30 Apr 2026, 23:59 BSTscheduled
- Contract details notice published11 May 2026, 11:50 BSTUK7
Commercial outcome & contract awards
Published awards, contracts and bid statistics, not a forecast| Awarded to | Value | Date | Status |
|---|---|---|---|
| Medivate30 Apr 2026 – 30 Jun 2026 | £95,000 | 16 Apr 2026 | Awarded |
Contracts
Purchase of Geister Peripheral and Major Vascular Access Instruments · Medivate
- Signed
- 7 May 2026
- Value
- £95,000
- Period
- 7 May 2026 – 30 Jun 2026
- Status
- active
No agreed KPIs: One off purchase
Contracting authority & participating public bodies
3 public bodies on the noticeClients of the procurement agent
- Velindre University NHS Trust Please note NHS Wales Shared Services Partnership (hosted by Velindre University NHS Trust) will manage this procurement on behalf of the contracting authority. Due to having the same identifiers, we're unable to reflect this in the notice options.Beneficiary authority
- NHS Wales Shared Services Partnership (hosted by Velindre University NHS Trust)Procuring entityNHS Wales Shared Services Partnership (NWSSP), hosted by Velindre University NHS Trust, provides essential shared services for NHS Wales by delivering high‑quality administrative, technical, and professional support across areas such as procurement, HR, finance, legal services, and more, helping Health Boards and Trusts operate efficiently and consistently across the country
Bidders & participating suppliers
1 commercial party on the notice- MedivateAwarded supplier
Official documents & specifications (3)
Official links; attachments are not copiedNotices published for this procedure
- Contract details notice Contract details notice on Find a Tender
- Contract award notice Contract award notice on Find a Tender
- Transparency notice Transparency notice on Find a Tender